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Abstract 
Background: Midlands Province started implementing the Isoniazid (INH) preventive therapy (IPT) program in Janu-
ary 2013. Shurugwi and Gokwe North were the piloting district hospitals. In May 2014, four more districts hospitals 
(Gokwe South, Gweru, Kwekwe and Zvishavane) started implementing IPT. Shurugwi District decentralized the pro-
gram to its rural health facilities in January 2014. A review of the Shurugwi IPT program, 2013 data, indicated that the 
majority of eligible clients were not started on IPT. None out of the 400 eligible clients were started on IPT in Novem-
ber against the 100 % target according to the World Health Organization and the National Tuberculosis (TB) Program. 
We conducted a study to evaluate the IPT program in Shurugwi District from January 2013 to August 2014.
Methods: The logical framework approach was used to evaluate inputs, processes, outputs and outcomes of the IPT 
program. An interviewer administered questionnaire was used to collect data from key informants. Checklists were 
used to collect data from IPT program records.
Results: Sixteen health facilities were implementing IPT in Shurugwi District. All the facilities had TB screening tools 
and three did not have TB screening algorithms. The district experienced medicine stock outs in 2013. One formal 
training at district level and on job trainings in implementing health facilities were done. From January 2013 to 
August 2014, Shurugwi District screened 6794 antiretroviral (ART) clients for TB. Out of those screened, 5255 were 
eligible for IPT and 2831 (54 %) were started on IPT. A total of 700 clients had completed the IPT 6 month’s course by 
August 2014. The dropout rate due to INH toxicity and TB was 0.6 % (n = 18) and 0.3 % (n = 8) respectively. Fifty-three 
advocacy and community sensitization meetings were done. The program had no Information Education and Com-
munication (IEC) materials.
Conclusion: The IPT program in Shurugwi District achieved half its target. This could be due to inadequate formally 
trained staff, lack of IEC materials, inadequate advocacy and community sensitization, non-availability of the INH 
300 mg single dose and inadequate INH 100 mg dose tablets in 2013. To improve the IPT program, there is need for 
routine advocacy, communication and social mobilization.
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Background
Isoniazid Preventive Therapy (IPT) is the provision of 
isoniazid (INH) to people at high risk of developing active 
tuberculosis (TB) [1]. It is a form of secondary prevention 
involving the provision of INH to prevent progression of 
latent TB to active TB. People with the Human Immu-
nodeficiency Virus (HIV) are 20–37 times more likely 
to develop active TB from latent TB than those without 
HIV [1]. HIV infection is the strongest risk factor for 
developing tuberculosis and has fuelled its resurgence, 
especially in sub-Saharan Africa [1]. In 2010, there were 
an estimated 1.1 million incident cases of tuberculosis 
among the 34 million people living with HIV worldwide 
[2]. It is estimated that between 30 and 50 % of HIV posi-
tive individuals die of TB, hence the need to prevent TB 
infection in HIV infected individuals through adminis-
tration of IPT for 6 months [2]. Studies have shown that 
IPT for up to 6 months may prevent TB infection in HIV 
positive clients [2]. Providing isoniazid to prevent TB 
among people living with HIV is a proven and interna-
tionally recommended strategy that has been effectively 
implemented in low resource settings [1].
The World Health Organization (WHO) recommends 
IPT as part of the three I’s for HIV/TB collaboration. 
These include, intensified TB case finding, INH preven-
tive therapy and Infection control for TB in health care 
and congregate settings [1]. The current recommended 
dose of IPT for adults is 300  mg of INH per day for 
6  months, with 36  months conditionally recommended 
in areas of high TB prevalence and transmission [1].
Adults and adolescents living with HIV should be 
screened with the WHO symptom checklist for TB, to 
rule out active TB infection. Those reporting one or more 
symptoms may have active TB and should be further 
evaluated and then treated for TB [3].
WHO has recently revised the guidelines on IPT that 
recommends the use of a simplified screening algorithm 
that relies on the absence of all four clinical symptoms 
(current cough, night sweats, fever, and weight loss) to 
identify people living with HIV (PLHIV) who have less 
likelihood of active TB disease and hence eligible for IPT 
[4]. This simplified symptom-based algorithm should be 
used for all adults living with HIV, including pregnant 
women, antiretroviral therapy (ART) clients and those 
who have successfully completed TB treatment [4].
According to WHO, before initiating a service to pro-
vide routine IPT to PLHIV, some prerequisites should 
be in place. These are a strong linkage between HIV 
care and TB control services, adequate capacity for HIV 
counseling, which should include information, education 
and counseling about TB, health care staff well trained 
in pre-treatment screening to exclude active pulmonary 
and extra pulmonary TB, resources available for close 
monitoring, supervision and evaluation of IPT outcomes, 
TB control programme with high adherence, high cure 
rates (≥70  %), case detection (≥70  %) and combined 
default/failure rates of less than 10 % [3].
Globally, almost a quarter of a million PLHIV, that is 
242,847, were reported to have received IPT between the 
period 2002 to 2009, showing a 19-fold increase over the 
period [3]. Despite the barriers and low uptake of IPT 
globally, IPT has been successfully implemented in sev-
eral settings. [3].
In sub-Saharan Africa, where the emergence of HIV has 
caused dramatic increases in tuberculosis (TB) case noti-
fications, IPT for HIV positive individuals was evaluated 
as a potential community-wide strategy for improving 
TB [2]. Zimbabwe continues to experience a major HIV 
driven TB epidemic with co-infection rates of 82  % [5]. 
Considerable progress has been made towards address-
ing the 12 point WHO collaborative TB/HIV activities. 
As of 2011, 92  % of all TB patients notified during the 
year had an HIV test result, 85 % of the HIV positive TB 
patients received cotrimoxazole and 71 % received ART 
[5]. Progress on implementation of the 3I’s has been 
very slow especially Isoniazid Preventive Therapy (IPT). 
Implementation of the intensified TB case finding (ICF) 
and isoniazid preventive therapy (IPT) initiative started 
in December 2012 with a feasibility phase being commis-
sioned in 10 selected sites across 5 provinces [5].
By the end of June 2014, the number of sites imple-
menting ICF/IPT had expanded to 46 in total with each 
of the 10 provinces in the country having at least two (2) 
to six (6) district level institutions [5]. The 46 health facil-
ities included 27 district hospitals, 1 provincial hospital 
and 2 central hospitals and a few clinics in Bulawayo City 
and Harare City. From January 2013 to May 2014, Zimba-
bwe was reported to have screened 425 190 HIV positive 
clients for TB. Out of the screened clients, 206,121 (48 %) 
were eligible for IPT and only 47,791 (23 %) of these were 
started on IPT. A total of 19,034 HIV positive clients 
were reported to have completed IPT [5].
Midlands Province started implementing IPT program 
in January 2013. Shurugwi and Gokwe North were the 
piloting district hospitals [6]. In May 2014, four more 
districts hospitals (Gokwe South, Gweru, Kwekwe, and 
Zvishavane) in the province started implementing the 
IPT program. Shurugwi District hospital started decen-
tralizing the program to its rural health facilities in Janu-
ary 2014 [6].
A review of the Shurugwi IPT program, 2013 data, 
indicated that the majority of clients, eligible for IPT 
were not started on IPT. In 2013, three out 62 (5  %), 
zero out of 400 (0 %) and 4 out of 400 (1 %) of the eligi-
ble HIV positive clients were started in August, Septem-
ber and November respectively [7]. The target for IPT 
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initiation is 100 % according to WHO and the National 
TB Program (NTP). All eligible clients are expected to be 
started on IPT. In December 2013, the National TB Pro-
gramme with close consultation with the Midlands Pro-
vincial Medical Director (PMD) and the District Health 
Executive (DHE) for Shurugwi District recommended 
the decentralization of the IPT program to rural health 
facilities in Shurugwi District. During the period under 
study, there were 16 health facilities in the district that 
were either ART initiating or follow up sites providing 
IPT. The IPT program was never evaluated.
Methods
A descriptive study was conducted in Shurugwi District. 
The logical framework approach was used to evalu-
ate inputs, processes, outputs and outcomes of the IPT 
program in Shurugwi District. Nurses in Charge (NIC) 
from the 15 health facilities, Opportunistic infections 
(OI)/ART Sister in Charge (SIC) from the district hospi-
tal, the District Medical Officer (DMO), TB coordinator, 
District Nursing Officer (DNO), Matron and Pharmacist 
were purposively recruited into the study as key inform-
ants. An interviewer administered questionnaire was 
used to collect data from key informants on resource 
availability, IPT processes being implemented both at 
district, health facility and community level, IPT pro-
gram achievements and challenge. Checklists were used 
to collect data from OI/ART records, TB records and 
IPT registers.
Ethical approval was obtained from the Provincial 
Medical Director (PMD) for Midlands Province, Health 
Studies Office (HSO), and DMO for Shurugwi District. 
Confidentiality was assured and maintained throughout 
the study. Participants were told that there were no mon-
etary benefits for participating and that participation was 
voluntary. Informed written consent was obtained from 
each participant.
Results
Demographic characteristics of key informants, Shurugwi 
District, Midlands Province, 2014
Out of the 21 study participants, the majority (71.4  %) 
were Nurses in Charge of the 15 health facilities (exclud-
ing the district hospital) offering IPT in Shurugwi Dis-
trict. The median years in service was 8  years (Q1 =  3; 
Q3 = 25) (Table 1).
Inputs injected into the IPT program, Shurugwi District, 
Midlands Province, January 2013 to August 2014
The IPT program started in January 2013 at the district 
hospital and was decentralized to 15 other health facili-
ties in January 2014. The number of health workers for 
the IPT program was 77 % (77 out of 100) the required. 
In 2013 the district hospital had both IPT guidelines and 
TB screening tools. In 2014 all the 16 health facilities had 
TB screening tools and only 3 did not have IPT guide-
lines. The district never produced or received Informa-
tion, Education and Communication (IEC) materials on 
IPT. All the 175 village health workers (VHW) were sen-
sitized on IPT in 2013 (Table 2).
Processes involved in running the IPT program in Shurugwi 
Districts, Midlands Province, 2013/2014
One formal training was conducted by the district and 
on job trainings were done in all health facilities in 2013 
and 2014. Advocacy and community sensitizations were 
mainly done in 2013 and were inadequately done in 2014.
Outputs of the IPT Program, Shurugwi District, Midlands 
Province, Jan 2013–Aug 2014
The district decentralized the IPT program to 15 health 
facilities in January 2014. A review of clinic records sug-
gested that from January 2013 to August 2014, Shurugwi 
district had screened 6794 (92  %) ART clients for TB. 
Out of those screened, 5255 (77 %) were eligible for IPT 
and 2831 (54  %) were started on IPT. About 10 (63  %) 
of the health facilities conducted a total of 53 commu-
nity sensitizations on IPT. However, the program had no 
IEC materials to compliment community sensitizations 
(Table 3).
Outcomes of the IPT Program, Shurugwi District, Midlands 
Province, January 2013 to August 2014
From January 2013 to August 2014, Shurugwi District 
started 54  % of the ART clients on IPT. A total of 700 
clients completed the INH 6 months course. Six (0.6 %) 
of the clients stopped IPT due to INH toxicity and eight 
(0.3 %) clients developed TB during IPT.
Table 1 Demographic characteristics of  key informants, 
Shurugwi District, Midlands Province, Zimbabwe, 2014
Variable Frequency n = 21 Percentage
Sex
 Male 6 29
 Female 15 71
Designation
 Nurses in charge 15/15 71.4
 District Medical Officer 1/1 4.8
 OI/ART Sister in Charge 1/1 4.8
 District Nursing Officer 1/1 4.8
 Matron 1/1 4.8
 Pharmacist 1/1 4.8
 TB coordinator 1/1 4.8
Years in service Median: 8 (Q1 = 3; Q3 = 25)
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Discussion
IEC materials provide key messages to educate com-
munities on the benefits of IPT, thereby marketing the 
program and clearing myths and misconceptions about 
IPT. Shurugwi District had no IEC materials on IPT. The 
National TB Program did not produce IEC materials to 
educate the public. Indumathi et al. found that program 
uptake can be enhanced by adequate education at the 
start of the therapy and during subsequent follow ups [7]. 
This implies that, community education through the dis-
tribution of posters, fliers and pamphlets is necessary to 
improve awareness and program uptake.
Advocacy and community sensitization are strategies 
that are implemented to enhance community participa-
tion and involvement of local leadership. If communi-
ties are involved and gain the ownership of the program, 
uptake improves. Advocacy and community sensitization 
for program success was not well capacitated by the dis-
trict hence low program uptake. The district conducted 
advocacy and community sensitizations for the IPT pro-
gram mainly when the program started in 2013. We con-
cluded that there was need to continue advocating for the 
program through adequate involvement of the local com-
munity leadership and the community at large in pro-
gram implementation. Similar findings were reported by 
Durovni et  al. where he recommended advocacy efforts 
for effective scale up of the program [8].
The target for IPT initiation is 100 % according to the 
World Health Organization and the National TB Pro-
gram. All eligible clients are expected to be started on 
IPT. In Shurugwi District, half of the eligible clients were 
started on IPT, however this was more than double the 
Table 2 Inputs used to running the IPT Program, Shurugwi District, Midlands Province, Zimbabwe, 2013/2014
Item Jan–Dec 2013 (1 site) Target Jan–Aug 2014 (16 sites) Target
Health workers involved in IPT 14 14 77 100
TB/IPT screening algorithms 2 2 17 20
TB screening tools 2 2 31 31
INH available for the period 224 boxes 840 boxes 3192 boxes 8200 boxes
Pyridoxine available for the period 75 bottles 288 bottles 1384 bottles 2952 bottles
Vehicle 1 1 1 1
Motor cycles 1 1 6 11
IEC materials (pamphlets) 0 2000 0 20,000
Table 3 Outputs of the IPT program in Shurugwi District, January 2013 to August 2014
Indicator Jan–Dec 2013  
(1 site)
Target 2014 Jan–Aug  
(16 sites)
Target Jan 2013–Aug 2014 
(16 sites)
OI clinic burden (cumulative for repeat visits) 10,347 10,347 19,381 19,381 29,728
Number of ART clients 6559 – 7385 – 7385
Number of ART clients screened for TB 6559 – 6449 – 6794
Number eligible for IPT 1797 1797 3458 3458 5255
Number started on IPT 933 1797 1898 3458 2831
Proportion of eligible clients started on IPT 52 % 100 55 % 100 54 %
Number of dropouts due to toxicity 1 0 17 0 18
Number of clients who developed TB during IPT 2 0 6 0 8
Number completed IPT 335 338 365 388 700
Number of Health facilities offering IPT 1 1 16 11 16
Number of HW trained on IPT (formal training) 41 77 0 36 41
Number of VHWs sensitized on IPT 175 175 0 175 175
Number of IEC materials on IPT distributed 0 2000 0 20,000 0
Number of IPT advocacy and sensitization  
meetings
4 12 49 100 53
Number of facilities doing advocacy  
and community sensitizations
1 1 10 16 11
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national picture where almost a quarter of the eligible cli-
ents were started on IPT from January 2013 to May 2014. 
INH stock outs were experienced in 2013 when the pro-
gram started leading to failure to start some clients on 
IPT in that same year. In Shurugwi District it was noted 
that some clients declined IPT due to fear of pill burden 
as they were already on ART and Cotrimoxazole, making 
a minimum of 10 tablets per day for those who accepted 
IPT.
All clients started on IPT are expected to complete 
the 6  months course. Treatment completion was high 
mainly because a small proportion stopped due to devel-
opment of INH toxicity and TB during IPT. Completion 
of the IPT course implies successful control of TB among 
ART clients for a period of 2–3  years after IPT. Similar 
findings were reported by, Durovni et  al. in 2010 who 
recorded a high adherence and completion rate among 
ART clients [8].
Screening algorithms provide important informa-
tion on eligibility criteria. Lack of IPT screening algo-
rithms may result in poor program implementation. 
The majority of the health facilities offering IPT in this 
study had TB screening algorithms. Granich et  al., in 
2010, found out that lack of standard operating proce-
dures (SOPs), guidelines and screening algorithms con-
tributes to the low availability and poor uptake of IPT 
[9]. WHO highlighted that the lack of guidelines was 
a barrier for IPT provision rather than patient related 
factors [10]. However, all health facilities were using 
TB screening tools for all clients, either HIV positive 
or not. This implies intensified case finding and is part 
of the 3Is for HIV/TB collaboration recommended by 
WHO [10].
In this study, we found out that the district hospital 
managed to decentralize the program to 15 other health 
facilities which is a positive achievement. However, chal-
lenges faced were shortage of staff in some clinics. Health 
workers were inadequate and overwhelmed because of 
many other competing program activities that call for 
their daily attention for example Provider Initiated Test-
ing and Counseling (PITC), TB screening and treat-
ment, (OI)/ART, Expanded Program on Immunization 
(EPI), Child growth monitoring, Prevention of Mother 
to Child Transmission of HIV (PMTCT) and deliveries. 
With adequate staff, IPT processes would be adequately 
implemented.
It was observed that the IPT program was highly 
effective at screening TB among ART clients, this 
is intensified case finding. The majority of ART cli-
ents were screened for TB at every review visit. This 
implies early detection and management of TB, hence 
reduced transmission to others. The key inform-
ants highlighted that It was also during clinic visits 
that clients were assessed for adherence to treatment 
through pill count.
Velle et al. found out that the most common reason for 
failure to adhere to and complete treatment was not visit-
ing the health facility frequently [11]. In this study treat-
ment completion was high, a few clients developed INH 
toxicity and TB during IPT. Half of the key informants 
interviewed highlighted that they were using a treatment 
buddie (close family member) to monitor adherence to 
treatment. Nolan et al. found out that IPT clients enrolled 
on community based directly observed preventive ther-
apy completed their treatment; hence a close monitoring 
of clients promotes treatment completion [12].
Conclusion
The IPT program in Shurugwi District achieved half its 
target. This could be due to inadequate formally trained 
staff, lack of IEC materials, inadequate advocacy and 
community sensitization, non-availability of the INH 
300 mg single dose and inadequate INH 100 mg dose tab-
lets in 2013. The district should improve Advocacy, Com-
munication and Social Mobilization (ACSM) for the IPT 
program.
Public health actions taken
As a result of this study, we gave health education on 
IPT to 15 ART clients, sourced and distributed A4 size 
TB/IPT screening algorithms to the clinics in need. We 
corrected some anomalies noted in IPT implementa-
tion where some clinics were not prescribing Pyridoxine 
together with INH to reduce the risk of developing side 
effects.
Recommendations
The study recommended the DMO to train health work-
ers who were not formally trained on IPT. The District 
Health Promotion Officer to produce and distribute IEC 
materials on IPT for educating health workers, clients 
and the community at large and to conduct advocacy, 
communication and social mobilization (ACSM) for IPT. 
Nat Pharm to provide the 300 mg single dose of INH for 
the IPT programme in order to reduce pill burden for 
clients.
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